Business / Finance

RSS

Emdeon, MZIHC enter services agreement

MZI HealthCare, LLC (MZIHC), a leading provider of health plan administration software, announced today that it has entered into a services agreement with Emdeon, a leading provider of revenue and payment cycle management and clinical information exchange solutions.

12 Apr 2012

Biomet third quarter net sales increase 5% to $708.9 million

Biomet, Inc. announced today financial results for its third fiscal quarter ended February 29, 2012.

12 Apr 2012

Takeda enters definitive agreement to acquire URL Pharma

Takeda Pharmaceutical Company Limited and URL Pharma Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma – a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent earn out payments.

12 Apr 2012

Nolato announces acquisition of Cope Allman Jaycare

As part of the Nolato Group's strategic expansion within medical technology and pharmaceuticals, Nolato has acquired the British company Cope Allman Jaycare for an initial purchase price of SEK 179 million (enterprise value) and a deferred consideration based on earnings up to and including the first quarter of 2014.

11 Apr 2012

Amgen enters agreement to acquire KAI Pharmaceuticals

Amgen and KAI Pharmaceuticals today announced an agreement under which Amgen will acquire KAI, a privately held pharmaceutical company based in South San Francisco.

11 Apr 2012

Simulations Plus second quarter net sales increase 6.4% to $2.789M

Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its second quarter of fiscal year 2012 ended February 29, 2012.

11 Apr 2012

3M announces acquisition of CodeRyte

3M announced today that it has acquired CodeRyte Inc., an industry leader in clinical natural language processing (NLP) technology and computer-assisted coding solutions for healthcare outpatient providers.

11 Apr 2012

Genstar Capital enters definitive agreement to acquire ERT

eResearchTechnology, Inc. (ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a definitive agreement to be acquired by affiliates of Genstar Capital LLC, a leading middle market private equity firm for $8.00 per share in cash in a transaction valued at approximately $400 million.

10 Apr 2012

Proteonomix provides corporate and clinical trial updates

Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today provided updates on its progress.

10 Apr 2012

Affiliate of Sun Capital acquires CornerStone

Sun Capital Partners, Inc., a leading private investment firm specializing in leveraged buyouts and investments in market-leading companies, today announced that an affiliate has acquired CornerStone Research & Development, Inc., a leading global contract manufacturer of top-branded vitamins and dietary supplements, from Mitsui & Co. (U.S.A.), Inc.

10 Apr 2012

Flextronics acquires Stellar Microelectronics

Flextronics today announced that it has completed its previously announced acquisition of Stellar Microelectronics.

10 Apr 2012

First Choice acquires FCMG

First Choice Healthcare Solutions, Inc. today announced its acquisition of First Choice Medical Group of Brevard, LLC, a multi-specialty medical group practice including orthopedics (both operative and non-operative), sports medicine, pain management and neurology located in Melbourne, Fla.

10 Apr 2012

Walgreens declares quarterly dividend of 22.5 cents per share

The board of directors of Walgreen Co. today declared a regular quarterly dividend of 22.5 cents per share, a 28.6 percent increase over the year ago dividend. The dividend is payable June 12, 2012, to shareholders of record May 21, 2012.

10 Apr 2012

Asheville Radiology Associates outsources billing to Zotec Partners

Zotec Partners, an industry leading provider of specialized medical billing and practice management services for the hospital-based specialty market, announces today that it is taking over billing operations for North Carolina-based Asheville Radiology Associates.

9 Apr 2012

Medutech to market ETView's VivaSight airway management platform

ETView Medical, Ltd. announced today that it has entered into a distribution agreement with Medutech Co., Ltd..

9 Apr 2012

Derma Sciences closes underwritten registered direct offering

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that it closed an underwritten registered direct offering of 2,125,000 shares of common stock at a price of $9.25 per share on April 5, 2012.

9 Apr 2012

Nautic Partners announces acquisition of Superior Vision

Nautic Partners LLC, a private equity firm with more than $2.5 billion of capital under management, and Superior Vision Holdings, Inc. today announced that Nautic, in partnership with the Superior Vision management team, acquired the Company.

9 Apr 2012

Medbox comments on new JOBS Act

Medbox, Inc. commented today on the new JOBS Act, recently passed by the United States House and Senate and signed by President Obama yesterday.

7 Apr 2012

MEDICREA first quarter sales increase 20% to 4.9 million euros

The MEDICREA Group, listed on Alternext by NYSE - Euronext Paris, a company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, announces its audited 2011 annual results approved by the Board meeting of March 29th 2012, as well as its sales for the 1st quarter of 2012.

7 Apr 2012

ISS recommends Illumina shareholders to vote against Roche's nominees

Roche released the following statement in response to a report issued by Institutional Shareholder Services recommending that shareholders of Illumina, Inc. vote against the election of Roche's independent director nominees to Illumina's Board of Directors.

From Illumina, Inc. 7 Apr 2012